美国急性呼吸衰竭患者的院际转运:范围综述
该范围综述检索Ovid Medline、Cochrane Database of Systematic Reviews、Cochrane Central Register of Controlled Trials、Embase、CINAHL Plus和American Psychological Association数据库,纳入2020年1月至2024年间美国成人(年龄>18岁)急性呼吸衰竭院际转运的研究,共检索3369篇,去重后筛选1748篇摘要,45篇全文审查,最终纳入16项研究。纳入研究多为回顾性分析,患者病因和严重程度异质;转运患者更年轻、病情严重程度高、更可能有商业保险。评估转运与非转运队列结局的研究发现死亡率无差异,但转运患者住院时间更长;早期转运改善结局的证据有限。作者结论指出证据稀疏,亟需进一步研究以定义最佳实践、指导临床决策并改善下游结局。
要点
- 纳入16项研究,多为回顾性分析,患者病因和急性呼吸衰竭严重程度异质。
- 转运患者较非转运队列更年轻、病情严重程度高、更可能有商业保险。
- 回顾性比较转运与非转运队列的研究发现死亡率无差异,但转运患者住院时间更长。
- 早期转运可能改善结局的证据有限。
- 作者认为证据稀疏,亟需进一步研究以定义最佳实践、指导临床决策并改善下游结局。
适用人群与场景
- 美国成人(年龄>18岁)急性呼吸衰竭患者,2020年1月至2024年间接受院际转运者。
研究设计与关键结果
- 研究类型:范围综述,检索Ovid Medline、Cochrane Database of Systematic Reviews、Cochrane Central Register of Controlled Trials、Embase、CINAHL Plus和American Psychological Association数据库,检索2020年1月至2024年间美国成人(年龄>18岁)急性呼吸衰竭院际转运的研究。
- 筛选流程:共检索3369篇文献,去重后筛选1748篇摘要,45篇进入全文审查,最终纳入16项研究。
- 纳入研究特征:多为回顾性分析,患者病因和急性呼吸衰竭严重程度异质。
- 转运与非转运队列比较:转运患者更年轻、病情严重程度高、更可能有商业保险。
- 结局:回顾性评估转运与非转运队列的研究发现死亡率无差异,但转运患者住院时间更长;早期转运改善结局的证据有限。
- 知识缺口: examining why patients get transferred 的数据缺乏。
证据类型、等级与局限
- 证据类型:范围综述,遵循PRISMA-ScR(Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews)进行数据提取。
- 局限:纳入研究多为回顾性分析,患者异质,证据稀疏;原文未报告其他局限性。
对床旁实践的改变
- 作者认为证据稀疏,亟需进一步研究以定义最佳实践、指导临床决策并改善下游结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Interhospital transfer of patients with acute respiratory failure (ARF) is relevant in the current landscape of critical care delivery. However, current transfer practices for patients with ARF are highly variable, poorly formalized, and lack evidence. We aim to synthesize the existing evidence, identify knowledge gaps, and highlight persisting questions related to interhospital transfer of patients with ARF.
DATA SOURCES: Ovid Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Embase, CINAHL Plus, and American Psychological Association.
STUDY SELECTION: We included studies that evaluated or described hospital transfers of adult (age > 18) patients with ARF between January 2020 and 2024 conducted in the United States. Using predetermined search terms and strategies, a total of 3369 articles were found across all databases. After deduplication, 1748 abstracts were screened by authors with 45 articles that advanced to full-text review. This yielded 16 studies that fit our inclusion criteria.
DATA EXTRACTION: The studies were reviewed in accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews by three authors.
DATA SYNTHESIS: Included studies were mostly retrospective analyses of heterogeneous patients with various etiologies and severity of ARF. Overall, transferred patients were younger, had high severity of illness, and were more likely to have commercial insurance compared with nontransferred cohorts. There is a paucity of data examining why patients get transferred. Studies that retrospectively evaluated outcomes between transferred and nontransferred cohorts found no differences in mortality, although transferred patients have a longer length of stay. There is limited evidence to suggest that patients transferred early in their course have improved outcomes.
CONCLUSIONS: Our scoping review highlights the sparse evidence and the urgent need for further research into understanding the complexity behind ARF transfers. Future studies should focus on defining best practices to inform clinical decision-making and improve downstream outcomes.
参考来源
- Ludwig A, Slota J, Nunes DA, et al. Interhospital Transfer of Patients With Acute Respiratory Failure in the United States: A Scoping Review. Crit Care Explor. 2024. PMID: 38968159. doi:10.1097/CCE.0000000000001120
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。